Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


20.06.2022

3 Int J Clin Pract
2 Intern Med
1 J Autoimmun
1 J Immunol
2 J Neuroimmunol
1 J Rheumatol
5 Mult Scler
1 N Engl J Med
1 Nat Rev Neurol
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Int J Clin Pract

  1. XU J, Chen D, Tian Y, Wang X, et al
    Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta-Analysis.
    Int J Clin Pract. 2022;2022:4308470.
    PubMed         Abstract available

  2. CHEN M, Liu J, Xiong Y, Xu G, et al
    Treatment of Idiopathic Membranous Nephropathy for Moderate or Severe Proteinuria: A Systematic Review and Network Meta-Analysis.
    Int J Clin Pract. 2022;2022:4996239.
    PubMed         Abstract available

  3. THARWAT S, Abdelsalam HA, Abdelsalam A, Nassar MK, et al
    COVID-19 Vaccination Intention and Vaccine Hesitancy among Patients with Autoimmune and Autoinflammatory Rheumatological Diseases: A Survey.
    Int J Clin Pract. 2022;2022:5931506.
    PubMed         Abstract available


    Intern Med

  4. SAKATA R, Chu PS, Kawaida M, Emoto K, et al
    Concurrent de novo Thymoma-associated Paraneoplastic Type 1 Autoimmune Hepatitis and Pure Red Cell Aplasia After Thymectomy: A Case Report and Literature Review.
    Intern Med. 2022 Jun 14. doi: 10.2169/internalmedicine.9743.
    PubMed         Abstract available

  5. HORINO T, Eguchi T, Inotani S, Hirose A, et al
    Overlap of Thrombotic Microangiopathy and Mesangial Proliferative Glomerulonephritis Caused by Combination Therapy with Atezolizumab and Bevacizumab.
    Intern Med. 2022 Jun 14. doi: 10.2169/internalmedicine.9425.
    PubMed         Abstract available


    J Autoimmun

  6. HUANG C, Yi P, Zhu M, Zhou W, et al
    Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial.
    J Autoimmun. 2022 Jun 8:102844. doi: 10.1016/j.jaut.2022.102844.
    PubMed         Abstract available


    J Immunol

  7. WONG KL, Li Z, Ma F, Wang D, et al
    SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against alpha2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases.
    J Immunol. 2022 Jun 10. pii: jimmunol.2100820. doi: 10.4049/jimmunol.2100820.
    PubMed         Abstract available


    J Neuroimmunol

  8. CHAN F, Riminton DS, Ramanathan S, Reddel SW, et al
    Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to "overlap" cases.
    J Neuroimmunol. 2022;369:577904.
    PubMed         Abstract available

  9. YAO Y, Zhang O, Gu L, Zhang X, et al
    Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis.
    J Neuroimmunol. 2022;369:577899.
    PubMed         Abstract available


    J Rheumatol

  10. LV C, You H, Xu L, Wang L, et al
    Coexisting of anti-Ro52 autoantibodies on anti-MDA5 autoantibodies-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220139. doi: 10.3899/jrheum.220139.
    PubMed         Abstract available


    Mult Scler

  11. MANUEL ESCOBAR J, Cortese M, Edan G, Freedman MS, et al
    Body mass index as a predictor of MS activity and progression among participants in BENEFIT.
    Mult Scler. 2022;28:1277-1285.
    PubMed         Abstract available

  12. W KOCH M, Mostert J, Repovic P, Bowen JD, et al
    Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS.
    Mult Scler. 2022;28:1286-1298.
    PubMed         Abstract available

  13. ANDERSEN JB, Wandall-Holm MF, Andersen PK, Sellebjerg F, et al
    Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort.
    Mult Scler. 2022;28:1239-1247.
    PubMed         Abstract available

  14. GIOVANNONI G, Singer BA, Issard D, Jack D, et al
    Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study.
    Mult Scler. 2022;28:1219-1228.
    PubMed         Abstract available

  15. CHO EB, Yeo Y, Jung JH, Jeong SM, et al
    Acute myocardial infarction risk in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea.
    Mult Scler. 2022 Jun 13:13524585221096964. doi: 10.1177/13524585221096964.
    PubMed         Abstract available


    N Engl J Med

  16. JEBARAJ A, Lin A
    Sclerokeratitis in Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:2221.
    PubMed        


    Nat Rev Neurol

  17. OH J, Bar-Or A
    Emerging therapies to target CNS pathophysiology in multiple sclerosis.
    Nat Rev Neurol. 2022 Jun 13. pii: 10.1038/s41582-022-00675.
    PubMed         Abstract available


    PLoS One

  18. ALLY N, Alli HD, Jeeva-Patel T, Mochan A, et al
    Optic neuritis: A South African hospital-based prospective study protocol.
    PLoS One. 2022;17:e0269514.
    PubMed         Abstract available

  19. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  20. ZAHOOR I, Suhail H, Datta I, Ahmed ME, et al
    Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.
    Proc Natl Acad Sci U S A. 2022;119:e2123265119.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: